excellent [50:] FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Manufacturers Gilead Sciences, Inc. Valeant Pharmaceuticals International, Inc. Drug Class Anti-angiogenic ophthalmic agents Related Drugs Macular Degeneration Eylea , Lucentis , aflibercept ophthalmic , ranibizumab ophthalmic , pegaptanib ophthalmic , Visudyne , More... Macugen Rating 1 User Review 9.0 /10 1 User Review 9.0 Rate it! agency
dollars Macugen ultimate
EmoticonEmoticon